Monday, November 18, 2024

Canada’s Politics and Government News Source Since 1989

Monday, November 18, 2024 | Latest Paper

Canada can’t afford to leave research out of the innovation conversation

To date, in the hopes of commercializing key biopharma products like vaccines, Canada has delivered significant dollars directly to companies. While this will certainly help bolster the industry—or at least elements of its operation—what’s further needed are investments in fundamental research in health and biomedicine.

Opinion
BY PETER N. LEWIS AND JEREMY HIROTA
December 28, 2021

Opinion | BY PETER N. LEWIS AND JEREMY HIROTA | December 28, 2021

More Opinion

It’s not promises that build the economy—it’s construction

OpinionBY RODRIGUE GILBERT

Progress towards partnership: Canada taking strides on African engagement

OpinionBY DAVID BOROTO

Canada is still climbing the mountain, but Murray Sinclair showed us the path forward

OpinionBY EDITORIAL

Trump’s win is bad for news for Trudeau

OpinionBY GERRY NICHOLLS

When the pendulum swings: how does the public service respond to political polarization?

OpinionBY LORI TURNBULL

Related Stories

Can biotechnology put patients’ needs ahead of profits?

OpinionBY SHARON BATT

Investing in highly qualified talent to grow Canada’s economy

OpinionBY ALICE AIKEN

It’s time for Canada to be the global research leader of tomorrow

OpinionBY STEPHEN J. TOOPE, ALAN BERNSTEIN

Fighting the next health crisis

OpinionBY E. RICHARD GOLD, ALED EDWARDS

In the innovation alphabet, R comes before D

OpinionBY MARTHA CRAGO AND PHILIPPE GROS